The Bone Growth Stimulators Market is projected to reach $1.94 billion by 2030, growing at a CAGR of 4.9% from 2023 to 2030. Increased reliability and reduced patient non-compliance are driving the use of these stimulators, which enhance the natural healing process and aid orthopedic treatments. Key players in the market include:
Orthofix International N.V.
Founded in 1980 and headquartered in Lewisville, Texas, Orthofix International N.V. provides advanced orthopedic and spine solutions globally. The company’s BioStim segment offers bone growth stimulators, with a presence in over 70 countries through direct and partner distribution.
DJO Global, Inc.
Established in 1978 and based in Vista, California, DJO Global, Inc. delivers orthopedic devices and rehabilitation products. Bone growth stimulators are available through the CMF brand, and the company operates extensively across North America, Europe, and Asia Pacific.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., headquartered in Warsaw, Indiana, and founded in 1927, focuses on musculoskeletal technologies. The company offers bone growth stimulators within its Spine and CMF segments, with operations spanning America, Europe, and Asia-Pacific.
Medtronic, plc
Founded in 1949 and based in Ireland, Medtronic, plc develops medical solutions aimed at pain relief and health restoration. Bone growth stimulators are part of the restorative therapies group, and the company has a strong presence in North America, Europe, and other regions.
